Guangdong Zhaoqing Xinghu Biotechnology Co., Ltd. (hereinafter referred to as the "Company") was a former agricultural microbial pharmaceutical factory established in 1964. It was converted to MSG in 1981 and converted from the former Zhaoqing MSG factory to establish a joint-stock company in 1992. It is a pilot project of shareholding reform in Guangdong Province. One of the companies. Listed on the Shanghai Stock Exchange in August 1994, with the stock abbreviation of "Xinghu Technology", stock code: 600866. In April 2009, Guangdong Guangxin Holding Group Co., Ltd. (hereinafter referred to as "Guangxin Group") acquired Zhaoqing State-owned Assets The state-owned controlling stake in Xinghu Technology held by the commission has become the controlling shareholder of the company. In 2019, the company acquired Sichuan Jiuling Pharmaceutical Technology Co., Ltd. In 2022, the company will acquire Ningxia Yipin Biotechnology Co., Ltd.

The company's main products include food additives, feed additives, pharmaceutical raw materials and intermediates, organic fertilizers, bio-based new material products, etc.

The company is a high-tech manufacturing enterprise with biofermentation and chemical synthesis as its core, and is a listing platform for the main business sectors of biopharmaceuticals and food health under Guangxin Group. The company mainly focuses on food additives, feed additives, pharmaceutical intermediates and raw materials, and its products cover many fields such as food processing, feed processing, and pharmaceutical health. Relying on the production bases of Yinchuan, Ningxia and Chifeng, Inner Mongolia, the company has achieved industrial layout in the northwest region and is positioned as a production base for bulk amino acid products; relying on the production bases of Daqing and Zhaodong, Heilongjiang to strengthen the company's layout advantages in the northeast region and is positioned as a new bio-fermentation product and high-end Production base for products and new materials; the Southwest Sichuan base is located at the research and development and production base for pharmaceutical intermediates and raw materials.

The company has more than ten high-level technology research and development platforms, including "National Certified Enterprise Technology Center", "Postdoctoral Research Mobile Workstation", "Guangdong Province Doctoral Workstation", "Guangdong Province Key Engineering Technology Center", "Guangdong Province Amino Acid Engineering Technology Center", and other high-level technology research and development platforms. It is Guangdong Province The organizational unit of the Microbial Manufacturing Health Industry Technology Innovation Alliance. The company has obtained national high-tech enterprises, national torch plan key high-tech enterprises, national torch plan outstanding high-tech enterprises, Guangdong Province technological innovation advantage enterprises, Guangdong Province innovative enterprises, Guangdong Province independent innovation benchmark enterprises, Guangdong Province independent innovation demonstration enterprises, Honors such as Guangdong Province Integrity Demonstration Enterprise. The holding subsidiary Yipin Bio has been recognized as a national enterprise technology center, a national technological innovation demonstration enterprise, a national key leading enterprise in rural industrialization, a national intellectual property demonstration enterprise, an advanced feed enterprise in the international cooperation of the "Belt and Road" and a top 500 private enterprises in China's manufacturing industry. , science and technology innovation team and other honors.